Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (27)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Fillenbaum, G. G.
Right arrow Articles by Schmader, K. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fillenbaum, G. G.
Right arrow Articles by Schmader, K. E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology Vol. 153, No. 2 : 137-144
Copyright © 2001 by The Johns Hopkins University School of Hygiene and Public Health


ORIGINAL CONTRIBUTIONS

Impact of Estrogen Use on Decline in Cognitive Function in a Representative Sample of Older Community-resident Women

Gerda G. Fillenbaum1, Joseph T. Hanlon2, Lawrence R. Landerman1 and Kenneth E. Schmader1,3,,5

1 Center for the Study of Aging and Human Development, Duke University Medical Center, Durham, NC.
2 College of Pharmacy, University of Minnesota, Minneapolis, MN.
3 Department of Medicine, Duke University Medical Center, Durham, NC.
4 Center for Health Services Research in Primary Care, VA Medical Center, Durham, NC.
5 Geriatric Research, Education and Clinical Center, VA Medical Center, Durham, NC.

The authors investigated whether postmenopausal estrogen use helps to maintain cognitive function; a brief screen, the Short Portable Mental Status Questionnaire (SPMSQ), was used. Information was gathered from a stratified, random sample of 1,907 African-American and White women (aged 65–100 years) participating in the longitudinal Duke Established Populations for Epidemiologic Studies of the Elderly project carried out in five urban and rural counties of North Carolina. All women were cognitively unimpaired in 1986–1987 and were evaluated 3 and 6 years later. Decline in cognitive function was measured as an increase of two or more errors on the SPMSQ and crossing of an SPMSQ threshold indicative of cognitive impairment. Recency and continuity of estrogen use were measured. Univariate analyses indicated that recent (crude odds ratio = 0.42, 95% confidence interval: 0.21, 0.86) and continuous (crude odds ratio = 0.32, 95% confidence interval: 0.13, 0.81) estrogen use reduced the risk of cognitive decline but not of cognitive impairment. After adjustment for demographic and health characteristics, protective effects became nonsignificant. While postmenopausal use of estrogen may be protective for Alzheimer's disease, current findings based on a brief cognitive screen suggest that it is not protective for cognitive decline related to aging.

blacks; cognition; estrogen replacement therapy; longitudinal studies; whites; women

Abbreviations: EPESE, Established Populations for Epidemiologic Studies of the Elderly; SPMSQ, Short Portable Mental Status Questionnaire.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Epidemiol RevHome page
N. Coley, S. Andrieu, V. Gardette, S. Gillette-Guyonnet, C. Sanz, B. Vellas, and A. Grand
Dementia Prevention: Methodological Explanations for Inconsistent Results
Epidemiol. Rev., November 1, 2008; 30(1): 35 - 66.
[Abstract] [Full Text] [PDF]


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
S. J. Fonda, R. Bertrand, A. O'Donnell, C. Longcope, and J. B. McKinlay
Age, Hormones, and Cognitive Functioning Among Middle-Aged and Elderly Men: Cross-Sectional Evidence From the Massachusetts Male Aging Study
J. Gerontol. A Biol. Sci. Med. Sci., March 1, 2005; 60(3): 385 - 390.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
M. S. Seelig, B. M. Altura, and B. T. Altura
Benefits and Risks of Sex Hormone Replacement in Postmenopausal Women
J. Am. Coll. Nutr., October 1, 2004; 23(5): 482S - 496S.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. H. Kang, J. Weuve, and F. Grodstein
Postmenopausal hormone therapy and risk of cognitive decline in community-dwelling aging women
Neurology, July 13, 2004; 63(1): 101 - 107.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
J. L. Mitchell, K. J. Cruickshanks, B. E. K. Klein, M. Palta, and D. M. Nondahl
Postmenopausal Hormone Therapy and Its Association With Cognitive Impairment
Arch Intern Med, November 10, 2003; 163(20): 2485 - 2490.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
B. B. Sherwin
Estrogen and Cognitive Functioning in Women
Endocr. Rev., April 1, 2003; 24(2): 133 - 151.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
S. A. de Moraes, M. Szklo, D. Knopman, and E. Park
Prospective Assessment of Estrogen Replacement Therapy and Cognitive Functioning: Atherosclerosis Risk in Communities Study
Am. J. Epidemiol., October 15, 2001; 154(8): 733 - 739.
[Abstract] [Full Text] [PDF]


Home page
JWatch PsychiatryHome page
More on Estrogen and Cognitive Function
Journal Watch Psychiatry, March 22, 2001; 2001(322): 17 - 17.
[Full Text]


Home page
JWatch GeneralHome page
More on Estrogen and Cognitive Function
Journal Watch (General), February 6, 2001; 2001(206): 2 - 2.
[Full Text]


Home page
JWatch Women's HealthHome page
More on Estrogen and Cognitive Function
Journal Watch Women's Health, February 6, 2001; 2001(206): 12 - 12.
[Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.